However, we can see from the results of the analysis that CLR expression has a tight and highly consistent positive correlation with a wide range of almost all of the crucial immune-checkpoint molecules, which suggests that high levels of expression of CLRs are linked with a highly immunosuppressive tumor microenvironment in bladder cancer. This evidence concerns the gene LARS1 and neoplasm.